Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 1/20 | 0.37 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.37 |
| ▸ | MCTS1 | Q9ULC4 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | HTR6 | P50406 | 5/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.34 |
| ▸ | BCL9 | O00512 | 1/20 | 0.34 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | STS | P08842 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 3/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | UBE2N | P61088 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1157089 | 0.91 | BCL9 (0.35) | SLC16A3SLC16A1MCTS1BCL9CTNNB1 | |
| SCHEMBL1156664 | 0.90 | SLC16A3 (0.39) | SLC16A3SLC16A1MCTS1HTR6BCL9 | |
| SCHEMBL1156772 | 0.88 | AOC3 (0.39) | RIPK1HTR6FFAR2BCL9CTNNB1 | |
| SCHEMBL1156910 | 0.86 | L3MBTL1 (0.39) | SLC16A3SLC16A1MCTS1RIPK1HTR6 | |
| SCHEMBL1156471 | 0.86 | SLC16A3 (0.34) | SLC16A3SLC16A1MCTS1RIPK1HTR2C | |
| SCHEMBL1157093 | 0.85 | SLC1A3 (0.36) | SLC16A3SLC16A1MCTS1RIPK1HTR6 | |
| SCHEMBL1156570 | 0.82 | LMNA (0.35) | SLC16A3SLC16A1MCTS1HTR6BCL9 | |
| SCHEMBL1156562 | 0.82 | HTR6 (0.40) | RIPK1HTR6STSRORCHTR2C | |
| SCHEMBL30089348 | 0.82 | HTR6 (0.40) | RIPK1HTR6STSRORCHTR2C | |
| SCHEMBL1157164 | 0.80 | HTR2C (0.42) | HTR6AOC3HTR2CSLC6A4GLS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8048909-B2 | Proton pump inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2336107-A2 | Proton pump inhibitors | Takeda Pharmaceutical Company Limited (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20110028476-A1 | PROTON PUMP INHIBITORS | KAJINO MASAHIRO | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028476-A1 | PROTON PUMP INHIBITORS | HRH2, HRH4, CYP2C19 | SLC16A3 2326/4885SLC16A1 1996/4885MCTS1 4581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.